Aubrey Ziegler
Allergy & Immunology · Fort Smith, ARNPI 1932188067
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 223 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,347 and has fallen 90.4% since, to $130 in 2025.
Across 223 payments — averaging $20.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$913
- GSK$780
- Sanofi$362
- Regeneron Healthcare Solutions, Inc.$327
- Sanofi-aventis U.S. LLC$253
- Inspire Medical Systems, Inc.$165
- plus $2K from 33 others
What the payments were for
- Food & beverage$4,35996%
- Education$1994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 43 | $913 |
| GSK | 59 | $780 |
| Sanofi | 11 | $362 |
| Regeneron Healthcare Solutions, Inc. | 16 | $327 |
| Sanofi-aventis U.S. LLC | 5 | $253 |
| Inspire Medical Systems, Inc. | 1 | $165 |
| Kaleo, Inc. | 8 | $134 |
| Biocryst US Sales Co., LLC | 1 | $122 |
| Boehringer Ingelheim | 6 | $111 |
| Xeris Pharmaceuticals, Inc. | 5 | $97 |
| Alk-abello, Inc | 5 | $91 |
| Genentech USA, Inc. | 5 | $83 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $79 |
| Teva Pharmaceuticals USA, Inc. | 5 | $75 |
| Currax Pharmaceuticals LLC | 5 | $72 |
| Stryker | 2 | $71 |
| Sanofi US Services Inc. | 1 | $67 |
| Kyowa Kirin, Inc. | 3 | $65 |
| Dexcom, Inc. | 3 | $61 |
| Lilly USA, LLC | 3 | $57 |
| Novartis | 3 | $56 |
| Ascendis Pharma Endocrinology Inc | 3 | $55 |
| Aimmune Therapeutics, Inc. | 2 | $49 |
| Insulet Corporation | 2 | $43 |
| Abbott | 2 | $42 |
| Novo Nordisk | 2 | $42 |
| Avanir Pharmaceuticals, Inc. | 3 | $40 |
| AbbVie(2 entities) | 2 | $38 |
| Ambu Inc. | 1 | $27 |
| Pharming Healthcare, Inc. | 1 | $25 |
| Tandem Diabetes Care, Inc. | 1 | $24 |
| Pfizer | 1 | $22 |
| Mylan Specialty L.p. | 1 | $20 |
| Amgen | 1 | $18 |
| Merck | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Shire North American Group Inc | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire Upper Airway Stimulation System$165
- DUPIXENT$125
- TRELEGY ELLIPTA$123
- Orladeyo$122
- TEZSPIRE$121
- FASENRA$104
How this compares
$4,558 in reported general payments places this provider in the 60th percentile of 26 allergy & immunology providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $13,485 |
| Fluticasone Propionate | 44 | $519 |
| Azelastine Hcl | 20 | $426 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $401 |
| Montelukast Sodium | 24 | $258 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $780 | $13,48521 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 26 allergy & immunology providers in Arkansas.
Other allergy & immunology in Fort Smith
- Blake ScheerLittle Rock$81K
- Jim IngramLittle Rock$62K
- Karl SitzLittle Rock$19K
- Jenny CampbellRogers$13K
- Curtis HedbergRogers$11K
- Stacy GriffinLittle Rock$10K
- Adesua WejinyaRogers$10K
- Ashley StonerLittle Rock$7K
- Anil BadhwarSearcy$7K
- Kim JacksonLittle Rock$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.